Cargando…

Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances

Antipsychotic drugs are widely prescribed medications, used for numerous psychiatric illnesses. However, antipsychotic drugs cause serious metabolic side effects that can lead to substantial weight gain and increased risk for type 2 diabetes. While individual drugs differ, all antipsychotic drugs ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Freyberg, Zachary, McCarthy, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441531/
https://www.ncbi.nlm.nih.gov/pubmed/28560263
http://dx.doi.org/10.1038/s41537-017-0018-4
_version_ 1783238277209260032
author Freyberg, Zachary
McCarthy, Michael J.
author_facet Freyberg, Zachary
McCarthy, Michael J.
author_sort Freyberg, Zachary
collection PubMed
description Antipsychotic drugs are widely prescribed medications, used for numerous psychiatric illnesses. However, antipsychotic drugs cause serious metabolic side effects that can lead to substantial weight gain and increased risk for type 2 diabetes. While individual drugs differ, all antipsychotic drugs may cause these important side effects to varying degrees. Given that the single unifying property shared by these medications is blockade of dopamine D(2) and D(3) receptors, these receptors likely play a role in antipsychotic drug-induced metabolic side effects. Dopamine D(2) and dopamine D(3) receptors are expressed in brain regions critical for metabolic regulation and appetite. Surprisingly, these receptors are also expressed peripherally in insulin-secreting pancreatic beta cells. By inhibiting glucose-stimulated insulin secretion, dopamine D(2) and dopamine D(3) receptors are important mediators of pancreatic insulin release. Crucially, antipsychotic drugs disrupt this peripheral metabolic regulatory mechanism. At the same time, disruptions to circadian timing have been increasingly recognized as a risk factor for metabolic disturbance. Reciprocal dopamine and circadian signaling is important for the timing of appetitive/feeding behaviors and insulin release, thereby coordinating cell metabolism with caloric intake. In particular, circadian regulation of dopamine D(2) receptor/dopamine D(3) receptor signaling may play a critical role in metabolism. Therefore, we propose that antipsychotic drugs’ blockade of dopamine D(2) receptor and dopamine D(3) receptors in pancreatic beta cells, hypothalamus, and striatum disrupts the cellular timing mechanisms that regulate metabolism. Ultimately, understanding the relationships between the dopamine system and circadian clocks may yield critical new biological insights into mechanisms of antipsychotic drug action, which can then be applied into clinical practice.
format Online
Article
Text
id pubmed-5441531
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54415312017-05-30 Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances Freyberg, Zachary McCarthy, Michael J. NPJ Schizophr Review Article Antipsychotic drugs are widely prescribed medications, used for numerous psychiatric illnesses. However, antipsychotic drugs cause serious metabolic side effects that can lead to substantial weight gain and increased risk for type 2 diabetes. While individual drugs differ, all antipsychotic drugs may cause these important side effects to varying degrees. Given that the single unifying property shared by these medications is blockade of dopamine D(2) and D(3) receptors, these receptors likely play a role in antipsychotic drug-induced metabolic side effects. Dopamine D(2) and dopamine D(3) receptors are expressed in brain regions critical for metabolic regulation and appetite. Surprisingly, these receptors are also expressed peripherally in insulin-secreting pancreatic beta cells. By inhibiting glucose-stimulated insulin secretion, dopamine D(2) and dopamine D(3) receptors are important mediators of pancreatic insulin release. Crucially, antipsychotic drugs disrupt this peripheral metabolic regulatory mechanism. At the same time, disruptions to circadian timing have been increasingly recognized as a risk factor for metabolic disturbance. Reciprocal dopamine and circadian signaling is important for the timing of appetitive/feeding behaviors and insulin release, thereby coordinating cell metabolism with caloric intake. In particular, circadian regulation of dopamine D(2) receptor/dopamine D(3) receptor signaling may play a critical role in metabolism. Therefore, we propose that antipsychotic drugs’ blockade of dopamine D(2) receptor and dopamine D(3) receptors in pancreatic beta cells, hypothalamus, and striatum disrupts the cellular timing mechanisms that regulate metabolism. Ultimately, understanding the relationships between the dopamine system and circadian clocks may yield critical new biological insights into mechanisms of antipsychotic drug action, which can then be applied into clinical practice. Nature Publishing Group UK 2017-04-10 /pmc/articles/PMC5441531/ /pubmed/28560263 http://dx.doi.org/10.1038/s41537-017-0018-4 Text en © The Author(s) 2017 This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Review Article
Freyberg, Zachary
McCarthy, Michael J.
Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
title Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
title_full Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
title_fullStr Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
title_full_unstemmed Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
title_short Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
title_sort dopamine d(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441531/
https://www.ncbi.nlm.nih.gov/pubmed/28560263
http://dx.doi.org/10.1038/s41537-017-0018-4
work_keys_str_mv AT freybergzachary dopamined2receptorsandthecircadianclockreciprocallymediateantipsychoticdruginducedmetabolicdisturbances
AT mccarthymichaelj dopamined2receptorsandthecircadianclockreciprocallymediateantipsychoticdruginducedmetabolicdisturbances